PROJECT

Projects

Summary of Investment Information

Project Number

33339

Company Name

HIKAL LIMITED

Date SPI Disclosed

Mar 1, 2013

Country

India

Region

South Asia

Projected Board Date

Apr 1, 2013

Environmental Category

B - Limited

Status

Completed

Last Updated Date

Jun 12, 2021

Department

Regional Industry - MAS Asia & Pac

Industry

Health, Education and Life Sciences

Previous Events

Approved : Nov 5, 2015
Signed : Jun 14, 2013
Invested : Jul 24, 2013

Sector

Pharmaceuticals and Medicine

Project Description

Hikal Limited (“Hikal” or the ‘Company”) undertakes custom manufacturing of key intermediates and active substances for pharmaceutical and agrochemical companies worldwide. Apart from the above, the Company provides process development and discovery research support.

Hikal is an existing IFC client and is embarking on a set of cleaner production initiatives at its facilities, including the establishment of briquette-fired boilers and a co-generation power plant, setting up a production line based on an enzymatic process that eliminates three key solvents from the production process, setting up a pilot plant to scale up the enzymatic processes for other products and establishment of effluent treatment and water conservation facilities.

Sponsor / Cost / Location

Development Impact

E&S Category Rationale / Risks and Mitigation